MedTrace Logo

Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing

NCT01639144 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 515

Last updated 2015-05-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if applying PRP and PPP to surgical sites and the closing incision helps prevent infection and slow wound healing.

Conditions

  • Elective Foot and Ankle Surgery.

Interventions

BIOLOGICAL

PRP and PPP

Autogenous PRP and PPP

Sponsors & Collaborators

  • Gary M. Kiebzak, Ph.D.

    lead OTHER

Principal Investigators

  • Gary M Kiebzak, Ph.D. · Center for Research & Grants

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2015-01-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01639144 on ClinicalTrials.gov